PMID

Data

Article Title

Organization

DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.

Central University of Punjab

Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II.

University of Manchester

Synthesis, biological evaluation, and structure-activity relationships of a novel class of apurinic/apyrimidinic endonuclease 1 inhibitors.

National Center For Advancing Translational Sciences

Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1).

Purdue University

Discovery of Macrocyclic Inhibitors of Apurinic/Apyrimidinic Endonuclease 1.

Boston University

Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).

Russian Academy of Sciences

Compounds and methods for inhibition of AP endonuclease-1/redox factor-1 (HAPE1) activity

University of Pittsburgh

Structure-based virtual screening toward the discovery of novel inhibitors of the DNA repair activity of the human apurinic/apyrimidinic endonuclease 1.

Universidade De Lisboa

Inhibition of apurinic/apyrimidinic endonuclease I's redox activity revisited.

Indiana University School of Medicine

Identification and characterization of human apurinic/apyrimidinic endonuclease-1 inhibitors.

University of Pittsburgh

Potent inhibition of human apurinic/apyrimidinic endonuclease 1 by arylstibonic acids.

The Johns Hopkins University

Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.

University of Southern California